VolitionRx Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats

Go back to VolitionRx Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats
VolitionRX Limited (NYSE: VNRX) Delayed: 1.37 -0.06 (4.2%)
Previous Close $1.43    52 Week High $5.86 
Open $1.43    52 Week Low $3.05 
Day High $1.45    P/E N/A 
Day Low $1.35    EPS $-0.45 
Volume 92,879